India's pharmaceutical glass market is seeing healthy growth and also facing a tight supply situation right now because of short-term production shortfalls.This is caused partly by furnace maintenance among large manufacturers and shifts in amber glass supply to the beer segment,which is growing strongly.The overall pharma glass market is growing steadily supported by both domestic demand for medicine as well as exports.Supply will grow once furnaces shut down for maintenance are fired again but production capacity will not increase in a very big way for the foreseeable future since only brownfield expansions are planned,not green field expansions involving entirely new capacity.Although demand is growing,container manufacturers do not find pharma glass profitable enough to invest to expand capacity in a big way yet.This is because margins are low in the type of pharma glass products they make.
展开▼
